These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7992834)

  • 1. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas.
    Boschman CR; Stryker S; Reddy JK; Rao MS
    Am J Pathol; 1994 Dec; 145(6):1291-5. PubMed ID: 7992834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
    Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53 expression in precancerous and malignant gastric mucosa.
    Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
    Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
    Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
    Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 expression in invasive pancreatic adenocarcinoma and precursor lesions.
    Norfadzilah MY; Pailoor J; Retneswari M; Chinna K; Noor LM
    Malays J Pathol; 2011 Dec; 33(2):89-94. PubMed ID: 22299208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
    Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
    Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.
    Zhang SY; Ruggeri B; Agarwal P; Sorling AF; Obara T; Ura H; Namiki M; Klein-Szanto AJ
    Arch Pathol Lab Med; 1994 Feb; 118(2):150-4. PubMed ID: 8311654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
    Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
    Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
    Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of p53 in human esophageal carcinoma and pre-malignant lesions in the esophagus].
    Dong Y; Liu S
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):58-60. PubMed ID: 8732116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.